LISATA THERAPEUTICS, INC. Extraordinary Item, Gain (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest (Deprecated 2019-01-31)
LISATA THERAPEUTICS, INC. (LSTA) reported Extraordinary Item, Gain (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest (Deprecated 2019-01-31) of $9.45 million for the 12-month period ending 2011-12-31, per its 10-K filed 2013-03-11.
Discontinued › Notes
us-gaap:ExtraordinaryItemNetOfTax · last filed 2013-03-11
- LISATA THERAPEUTICS, INC. extraordinary item, gain (loss), net of tax, including portion attributable to noncontrolling interest (deprecated 2019-01-31) for fiscal 2011 was $9.45M.
| Period end | Extraordinary Item, Gain (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest (Deprecated 2019-01-31) 12 month | Extraordinary Item, Gain (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest (Deprecated 2019-01-31) 12 month as first filed |
|---|---|---|
| 2011-12-31 | $9.45M 10-K · filed 2013-03-11 | -$9.45M 8-K · filed 2012-08-15 |
| 2010-12-31 | $3.91M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |